| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.58B | 10.67B | 7.85B | 6.48B | 5.78B | 4.71B |
| Gross Profit | 4.50B | 4.18B | 3.02B | 2.53B | 2.22B | 1.93B |
| EBITDA | 2.64B | 2.31B | 2.78B | 2.40B | 2.04B | 1.71B |
| Net Income | 1.41B | 936.85M | 951.68M | 340.09M | 141.21M | 336.14M |
Balance Sheet | ||||||
| Total Assets | 67.22B | 67.30B | 51.04B | 44.01B | 37.89B | 34.91B |
| Cash, Cash Equivalents and Short-Term Investments | 4.70B | 5.03B | 3.51B | 1.99B | 631.68M | 269.26M |
| Total Debt | 19.98B | 21.38B | 16.76B | 16.12B | 14.96B | 14.68B |
| Total Liabilities | 22.29B | 24.10B | 18.47B | 17.64B | 16.50B | 15.91B |
| Stockholders Equity | 43.79B | 42.13B | 31.96B | 25.40B | 20.29B | 17.64B |
Cash Flow | ||||||
| Free Cash Flow | 2.54B | 2.85B | 2.20B | 1.55B | 1.30B | 1.26B |
| Operating Cash Flow | 2.95B | 2.88B | 2.26B | 1.60B | 1.33B | 1.28B |
| Investing Cash Flow | -9.29B | -10.51B | -5.51B | -5.71B | -3.70B | -4.52B |
| Financing Cash Flow | 7.49B | 9.00B | 4.91B | 5.45B | 2.76B | 1.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $9.81B | 25.48 | 8.67% | 3.56% | 58.48% | 70.32% | |
77 Outperform | $150.08B | 47.47 | 3.51% | 1.51% | 37.51% | -160.87% | |
76 Outperform | $14.39B | 21.54 | 12.40% | 6.11% | 13.95% | 27.68% | |
70 Outperform | $5.28B | 29.65 | 5.61% | 6.47% | 13.50% | 7.25% | |
69 Neutral | $13.77B | 14.75 | 2.88% | 7.73% | 2.71% | -19.70% | |
69 Neutral | $43.86B | 174.12 | 2.10% | 2.45% | 20.67% | 67.64% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% |